Implementation of a Skull-Conformal Phased Array for Transcranial Focused Ultrasound Therapy.
Authors: Adams C, Jones RM, Yang SD, Kan WM, Leung K, Zhou Y, Lee KU, Huang Y, Hynynen K
To implement a skull-conformal phased array for ultrasound-guided transcranial focused ultrasound therapy with improved patient comfort. Using patient-specific computed tomography and MRI neuroimaging data, tightly-conforming helmet scaffolds were designed computationally. The helmet scaffolds were designed to hold reusable transducer modules at near-normal incidence in an optimal configuration for the treatment location(s) of interest. Numerical simulations of trans-skull ultrasound propagation were performed to evaluate different conformal array designs and to compare with hemispherical arrays similar to those employed clinically. A 4096-element phased array was constructed by 3D printing a helmet scaffold optimised for an ex vivo human skullcap, and its performance was evaluated via benchtop and in vivo experiments. Acoustic field measurements confirmed the system's ability to focus through human skull bone using simulation-based transcranial aberration corrections. Preliminary in vivo testing demonstrated safe trans-human skull blood-brain barrier (BBB) opening in rodents. Patient-specific conformal ultrasound phased arrays appear to be a feasible and safe approach for conducting transcranial BBB opening procedures. Skull-conformal phased arrays stand to improve patient comfort and have the potential to accelerate the adoption of transcranial FUS therapy by improving access to the technology.
Introduction
Purpose
Drug delivery with BBB opening
Study Objective
To implement a skull-conformal phased array for ultrasound-guided transcranial focused ultrasound therapy with improved patient comfort.
Animal model / Human subject
Rodents (species not specified); strain Sprague-Dawley; age not reported; sex male
Disease model
Healthy
MRI or image guidance method
Patient-specific CT and MRI neuroimaging data (image-guided planning) with simulation-based transcranial aberration correction
Targeted brain region(s)
Mid-Brain
Cargo name and characteristics
Gadovist (gadobutrol) — gadolinium-based MRI contrast agent (small molecule)
Route of administration
Intravenous
Outcomes and Safety
Summary of Outcomes
A 4096‑element, patient‑specific skull‑conformal phased array with simulation‑based transcranial aberration corrections produced focused ultrasound through human skull bone ex vivo and enabled safe blood–brain barrier (BBB) opening across the skull in rodents in vivo. The paper does not report specific focused‑ultrasound parameter sets (e.g., frequency, pressure, duty cycle) as being tested or identified as successful.
Safety-related matter
Preliminary in vivo testing demonstrated safe trans-skull blood–brain barrier (BBB) opening in rodents, and the authors conclude the patient-specific conformal arrays appear feasible and safe; no adverse effects were reported.
Brain Region
Ultrasound Parameters
Ultrasound instrument
4096-element phased array
FUS Frequency
520 kHz
FUS Pressure
0.31-0.37 Mpa
FUS Mode
pulsed
Pulse duration
10 ms
Duration of a single FUS session
120 seconds (2 minutes)
Focal Characteristics
Focal depth: None; Focal length: None; Aperture size: None
Treatment frequency
single session
We are open to feedback. If you see a mistake or have a suggestion, please contact us.
← Back to Search